Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (501-510 of 675) with videos related to

Pageof 68
Sort By:
Nutrition Reviews|April 4, 2017
Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trialsSorin Ursoniu, Amirhossein Sahebkar, Maria-Corina Serban, et al.
Journal of Andrology|May 27, 2006
Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contractionDavid H W Lau, Cecil S Thompson, James F Bellringer, et al.
Expert Opinion on Therapeutic Targets|December 6, 2011
Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunctionCostas Tsioufis, Athanasios Aggelis, Kyriakos Dimitriadis, et al.
Annals of Clinical Biochemistry|March 1, 2011
Point of care testing is appropriate for National Health Service health checkAnjly Jain, Jahm Want Persaud, Nandini Rao, et al.
Angiology|January 12, 2011
Comparison of fibrate, ezetimibe, low- and high-dose statin therapy for the dyslipidemia of the metabolic syndrome in a mouse modelKosmas I Paraskevas, Alkistis Pantopoulou, Ioannis S Vlachos, et al.
Annals of Clinical and Laboratory Science|November 15, 2007
Gender influence on postprandial lipemia in heterozygotes for familial hypercholesterolemiaGenovefa D Kolovou, Katherine K Anagnostopoulou, Dimitris S Damaskos, et al.
Current Drug Targets|March 14, 2007
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsVasilios G Athyros, Dimitri P Mikhailidis, Anna I Kakafika, et al.
Journal of the American Academy of Dermatology|November 2, 2013
Serum endocan levels as a marker of disease activity in patients with Behçet diseaseIlknur Balta, Sevket Balta, Ozgul Mustu Koryurek, et al.
Plos One|November 23, 2021
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot studyAtul Goyale, Anjly Jain, Colette Smith, et al.
Vascular|October 14, 2021
Incidence of contrast-induced acute kidney injury in patients with acute mesenteric ischemia and identification of potential predictive factorsEmmanuel Augène, Fabien Lareyre, Julien Chikande, et al.
Pageof 68

Showing results (501-510 of 675) with videos related to

Sort By:
Pageof 68
Nutrition Reviews|April 4, 2017
Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trialsSorin Ursoniu, Amirhossein Sahebkar, Maria-Corina Serban, et al.
Journal of Andrology|May 27, 2006
Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contractionDavid H W Lau, Cecil S Thompson, James F Bellringer, et al.
Expert Opinion on Therapeutic Targets|December 6, 2011
Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunctionCostas Tsioufis, Athanasios Aggelis, Kyriakos Dimitriadis, et al.
Annals of Clinical Biochemistry|March 1, 2011
Point of care testing is appropriate for National Health Service health checkAnjly Jain, Jahm Want Persaud, Nandini Rao, et al.
Angiology|January 12, 2011
Comparison of fibrate, ezetimibe, low- and high-dose statin therapy for the dyslipidemia of the metabolic syndrome in a mouse modelKosmas I Paraskevas, Alkistis Pantopoulou, Ioannis S Vlachos, et al.
Annals of Clinical and Laboratory Science|November 15, 2007
Gender influence on postprandial lipemia in heterozygotes for familial hypercholesterolemiaGenovefa D Kolovou, Katherine K Anagnostopoulou, Dimitris S Damaskos, et al.
Current Drug Targets|March 14, 2007
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsVasilios G Athyros, Dimitri P Mikhailidis, Anna I Kakafika, et al.
Journal of the American Academy of Dermatology|November 2, 2013
Serum endocan levels as a marker of disease activity in patients with Behçet diseaseIlknur Balta, Sevket Balta, Ozgul Mustu Koryurek, et al.
Plos One|November 23, 2021
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot studyAtul Goyale, Anjly Jain, Colette Smith, et al.
Vascular|October 14, 2021
Incidence of contrast-induced acute kidney injury in patients with acute mesenteric ischemia and identification of potential predictive factorsEmmanuel Augène, Fabien Lareyre, Julien Chikande, et al.
Pageof 68